Abstract
Eosinophilic gastrointestinal diseases (EGIDs) are chronic immune/antigen-mediated disorders characterized by eosinophilic inflammation. They can affect the esophagus (eosinophilic esophagitis [EoE]), the stomach, and the small bowel (eosinophilic gastroenteritis [EGE]) and the colon (eosinophilic colitis [EC]). Medical therapies consist primarily of proton pump inhibitors (PPIs) or orally administered topical corticosteroids for EoE. Systemic corticosteroids or biologics are used in case of refractory EoE and in case of EGE and EC, despite the well-known adverse events associated with their long-term administration.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: The Journal of Allergy and Clinical Immunology: In Practice
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
